Actively Recruiting
MAPS PrEP Van Study
Led by Duke University · Updated on 2026-01-20
20
Participants Needed
1
Research Sites
45 weeks
Total Duration
On this page
Sponsors
D
Duke University
Lead Sponsor
N
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborating Sponsor
AI-Summary
What this Trial Is About
For this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.
CONDITIONS
Official Title
MAPS PrEP Van Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Active drug injection user and/or sexually active
- Referred from the Syringe Service Program
You will not qualify if you...
- Positive HIV status
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Duke Department of Population Health Sciences
Durham, North Carolina, United States, 27701
Actively Recruiting
Research Team
A
Amelia R Ashkin-Baker, BA
CONTACT
M
Madelene Travis, BA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here